EA200601373A1 - Нитрат бутоконазола высокой степени чистоты с частицами заданного размера и способ его получения - Google Patents

Нитрат бутоконазола высокой степени чистоты с частицами заданного размера и способ его получения

Info

Publication number
EA200601373A1
EA200601373A1 EA200601373A EA200601373A EA200601373A1 EA 200601373 A1 EA200601373 A1 EA 200601373A1 EA 200601373 A EA200601373 A EA 200601373A EA 200601373 A EA200601373 A EA 200601373A EA 200601373 A1 EA200601373 A1 EA 200601373A1
Authority
EA
Eurasian Patent Office
Prior art keywords
particles
nitrate
given size
obtaining
high degree
Prior art date
Application number
EA200601373A
Other languages
English (en)
Other versions
EA009238B1 (ru
Inventor
Ласло Цибула
Ласло Добаи
Эва Веркне Папп
Юдит Надьне Багди
Ференц Шебёк
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт. filed Critical Рихтер Гедеон Ведьесети Дьяр Рт.
Publication of EA200601373A1 publication Critical patent/EA200601373A1/ru
Publication of EA009238B1 publication Critical patent/EA009238B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Одним из объектов настоящего изобретения является нитрат бутоконазола высокой степени чистоты формулы (I), содержащий максимум 0,1 мас.% химических примесей, в котором по меньшей мере 95% частиц вещества имеют диаметр менее 75 мкм, в то время как по меньшей мере 99% частиц имеют диаметр менее 250 мкм, и способ его получения. Фармацевтическая композиция, содержащая в качестве активного ингредиента нитрат бутоконазола высокой степени чистоты с частицами заданного размера в смеси с известными добавками, также включена в объем изобретения.
EA200601373A 2004-01-27 2005-01-25 Нитрат бутоконазола высокой степени чистоты с частицами заданного размера и способ его получения EA009238B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0400270A HUP0400270A3 (en) 2004-01-27 2004-01-27 High purity butoconazole nitrate having a predetermined particle size and process for the production of the same
PCT/HU2005/000002 WO2005070897A1 (en) 2004-01-27 2005-01-25 High purity butoconazole nitrate with specified particle size and a process for preparation thereof

Publications (2)

Publication Number Publication Date
EA200601373A1 true EA200601373A1 (ru) 2006-12-29
EA009238B1 EA009238B1 (ru) 2007-12-28

Family

ID=89981937

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601373A EA009238B1 (ru) 2004-01-27 2005-01-25 Нитрат бутоконазола высокой степени чистоты с частицами заданного размера и способ его получения

Country Status (9)

Country Link
US (1) US7625935B2 (ru)
EP (2) EP1709005B1 (ru)
JP (1) JP4795973B2 (ru)
DE (1) DE602005015417D1 (ru)
EA (1) EA009238B1 (ru)
HU (1) HUP0400270A3 (ru)
NO (1) NO20063805L (ru)
UA (1) UA87674C2 (ru)
WO (1) WO2005070897A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102649796A (zh) * 2011-02-24 2012-08-29 四川滇虹医药开发有限公司 一种硝酸布康唑中间体的制备方法
CN105198816B (zh) * 2015-10-09 2018-05-01 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑的方法
CN105175341B (zh) * 2015-10-09 2017-12-26 株洲千金药业股份有限公司 一种工业化合成硝酸布康唑中间体的方法
CN105218455B (zh) * 2015-10-09 2018-07-03 株洲千金药业股份有限公司 一种工业化连续生产硝酸布康唑的方法
CN105218456B (zh) * 2015-10-09 2018-07-03 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑的方法
CN105175338B (zh) * 2015-10-09 2018-03-23 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑中间体的方法
CN105198814B (zh) * 2015-10-09 2018-03-20 株洲千金药业股份有限公司 一种工业化生产硝酸布康唑中间体的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1567431A (en) * 1977-01-10 1980-05-14 Syntex Inc 1-(2-(halophenylthio)-4-(p-chloro- or-flrorophenyl)-n-butyl) imidazoles

Also Published As

Publication number Publication date
WO2005070897A1 (en) 2005-08-04
UA87674C2 (ru) 2009-08-10
EA009238B1 (ru) 2007-12-28
HU0400270D0 (en) 2004-04-28
HUP0400270A3 (en) 2007-09-28
EP1709005B1 (en) 2009-07-15
EP1903035A3 (en) 2009-01-07
JP4795973B2 (ja) 2011-10-19
US7625935B2 (en) 2009-12-01
DE602005015417D1 (de) 2009-08-27
EP1709005A1 (en) 2006-10-11
EP1903035A2 (en) 2008-03-26
JP2007519699A (ja) 2007-07-19
US20080221190A1 (en) 2008-09-11
HUP0400270A2 (hu) 2005-12-28
NO20063805L (no) 2006-08-25

Similar Documents

Publication Publication Date Title
EA200601373A1 (ru) Нитрат бутоконазола высокой степени чистоты с частицами заданного размера и способ его получения
MXPA05010137A (es) Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
HRP20050641A2 (en) New carboxylic acids and the esters thereof, pharmaceutical compositions containing these compounds and processes for the preparation thereof
IL168836A (en) Pyrimidine-sulfamides and their use as endothelin receptor antagonist
MX2007013065A (es) Derivados de dihidrobenzofurano y usos de los mismos.
DE60305724D1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
CA2462606A1 (en) Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer
TW200833326A (en) Chemical compounds 572
NO20063517L (no) Ny krystallinsk form v av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
PL1750862T3 (pl) Kompozycja farmaceutyczna zawierająca irbesartan
EP1993567A4 (en) PER OS ADMINISTRABLE GALLIUM PREPARATIONS AND METHODS OF USE
EA201170289A1 (ru) Фармацевтические композиции и способы их получения при низкой концентрации примесей
EA200701107A1 (ru) Твердая фармацевтическая композиция, содержащая валсартан
EA201000752A1 (ru) Фармацевтическая композиция, содержащая эзетимиб
SE0302139D0 (sv) Novel compounds
TW200604197A (en) New compounds
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
WO2005000840A8 (en) Substituted diketopiperazines and their use as oxytocin antagonists
NZ598467A (en) Stable sns-595 compositions and methods of preparation
MXPA05008601A (es) Derivados de benzamida como agonistas de oxitocina y antagonistas de vasopresina.
EA200601641A1 (ru) Кристаллическая композиция, содержащая оксалат эсциталопрама
TW200621774A (en) Bicyclononene derivatives

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM